Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies
Transition to a fermentation-based globally integrated CDMO platform
The multi-target collaboration combines Regeneron’s industry-leading antibody capabilities with Parabilis’ novel Helicon peptide platform
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
Expands manufacturing push & locks in major growth deals
Subscribe To Our Newsletter & Stay Updated
